Anti-Inflammatory Therapeutics Market

1
Global Anti-Inflammatory Therapeutics Market
Published Date 22 June 2015 No. of pages
136
2
 
Introduction to Global Anti-inflammatory
Therapeutics Market
Inflammation is triggered by the defense system
of the body in response to harmful stimuli,
damaged cells, irritants and microorganisms.
Inflammation is the mechanism of innate immunity,
which seeks to eliminate the cause of injury,
clear dead and necrotic cells and heal injured
tissues. Sometimes, the body defense system
inappropriately triggers inflammation against its
own cells, resulting in incurable inflammatory
autoimmune diseases such as arthritis, asthma and
chronic obstructive pulmonary disease (COPD).
According to World Health Organization (WHO),
approximately 235 million people suffer from
asthma in the world. Symptomatic relief during
the inflammation provides relief to the patients
suffering from inflammatory autoimmune
diseases The global anti-inflammatory
therapeutics market is expected to grow at a CAGR
of 5.9 over the forecast period, owing to the
emergence of anti-inflammatory biologics that are
more targeted, effective and with lesser side
effects as compared to conventional drugs. In
addition, they are also difficult to imitate due
to their complex molecular structure and origin.
The global anti-inflammatory market has been
driven by factors such as increasing autoimmune
and respiratory conditions, new drugs in pipeline
and increasing adoption of anti-inflammatory
drugs. Moreover, increasing awareness of
anti-inflammatory therapeutics and attractive
government initiatives in the Asia-Pacific and
LAMEA region are expected to drive the market
during the analysis period.
3
 
Introduction
Scope of the Report
Key Benefits
Key Audiences
4
 
KEY BENEFITS

• The report provides a quantitative analysis of
  the current market and estimations during 2014 -
  2020 that assist in identifying the prevailing
  market opportunities to capitalize.
• Competitive intelligence (of leading
  manufacturers and distributors of
  anti-inflammatory therapeutics) helps in
  understanding the competitive scenario across the
  geographies.
• Comprehensive analysis of factors that drive and
  restrict the growth of the global
  anti-inflammatory therapeutics market is
  provided.
• SWOT analysis enables to study the internal
  environment of the leading companies for strategy
  formulation.
• The Country level analysis of anti-inflammatory
  therapeutics market conditions has been provided
  in this report.

5
 
Table of Contents

• Introduction
• Executive Summary
• Market Overview
• Global Anti-inflammatory Therapeutics Market By
  Indication
• Global Anti-inflammatory Therapeutics Market By
  Drug Class
• Global Anti-inflammatory Therapeutics Market By
  Geography
• Company Profiles

6
 
Global Anti-inflammatory Therapeutics Market
Overview

• Report Description
• CXO Perspective
• Market Definition and Scope
• Key Findings
• Porters Five Force Analysis
• Market Share Analysis, 2014
• Market Dynamics
• Anti-inflammatory Biologics

7
 
Global Anti-inflammatory Therapeutics Market By
Segments
8
 
Global Anti-inflammatory Therapeutics Market, By
Geography
 North America, Europe, Asia Pacific, LAMEA
9
 
Company Profiles

1. Pfizer Inc.
2. AbbVie Inc.
3. Johnson Johnson
4. GlaxoSmithKline plc
5. Merck Co., Inc.
6. Novartis AG
7. F. Hoffmann-La Roche AG
8. Eli Lily and Company
9. AstraZeneca PLC.
10. Amgen Inc.

10
 
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/anti-inflamma
tory-therapeutics-market
Follow Us On